Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Travoprost with vs without BAK in Glaucoma or Ocular Hypertension
NCT00288951Phase 3Completed
- Sponsor
- Alcon Inc.
- Start
- Oct 2004
- Primary completion
- Jun 2005
- Modality
- Prodrugs/Conditional Activator Small Molecules
01
Overview
A Phase 3 trial of travoprost in open-angle glaucoma (OAG), ocular hypertension, sponsored by Alcon Inc.. Started Oct 2004; status: completed.
02
Drugs
travoprost
03
Conditions
open-angle glaucoma (OAG)ocular hypertension
Beyond the preview
Go deeper on NCT00288951.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00288951.